Trademark: 79185130
Word
KINVITRAR
Status
Dead
Status Code
709
Status Date
Friday, March 24, 2023
Serial Number
79185130
Registration Number
5038603
Registration Date
Tuesday, September 13, 2016
Mark Type
4000
Filing Date
Wednesday, February 3, 2016
Published for Opposition
Tuesday, June 28, 2016
Cancellation Date
Friday, March 24, 2023

Trademark Owner History
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical purposes

Trademark Events
Jan 21, 2024
Total Invalidation Processed By The Ib
Dec 28, 2023
Total Invalidation Of Reg Ext Protection Sent To Ib
Dec 28, 2023
Invalidation Processed
Nov 24, 2023
Total Invalidation Of Reg Ext Protection Created
Mar 24, 2023
Cancelled Section 71
Sep 13, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 9, 2017
Notification Of Possible Opposition - Processed By Ib
Feb 24, 2017
Final Decision Transaction Processed By Ib
Feb 2, 2017
Final Disposition Notice Sent To Ib
Feb 2, 2017
Final Disposition Processed
Dec 13, 2016
Final Disposition Notice Created, To Be Sent To Ib
Sep 13, 2016
Registered-Principal Register
Jun 28, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2016
Published For Opposition
Jun 8, 2016
Notification Of Possible Opposition Sent To Ib
Jun 8, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 8, 2016
Notification Of Notice Of Publication E-Mailed
May 27, 2016
Refusal Processed By Ib
May 26, 2016
Approved For Pub - Principal Register
May 25, 2016
Teas/Email Correspondence Entered
May 25, 2016
Correspondence Received In Law Office
May 25, 2016
Teas Response To Office Action Received
May 17, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
May 17, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 9, 2016
Non-Final Action Mailed - Refusal Sent To Ib
May 9, 2016
Refusal Processed By Mpu
May 7, 2016
Non-Final Action (Ib Refusal) Prepared For Review
May 6, 2016
Non-Final Action Written
May 4, 2016
Assigned To Examiner
Apr 1, 2016
Application Filing Receipt Mailed
Mar 28, 2016
New Application Office Supplied Data Entered
Mar 25, 2016
Limitation From Original Application Entered
Mar 24, 2016
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24